The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer

The lack of response to therapy in pancreatic ductal adenocarcinoma (PDAC) patients has contributed to PDAC having one of the lowest survival rates of all cancer types. The poor survival of PDAC patients urges the exploration of novel treatment strategies. Immunotherapy has shown promising results i...

Descripción completa

Detalles Bibliográficos
Autores principales: Stouten, Imke, van Montfoort, Nadine, Hawinkels, Lukas J. A. C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218125/
https://www.ncbi.nlm.nih.gov/pubmed/37240052
http://dx.doi.org/10.3390/ijms24108707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218125/
https://www.ncbi.nlm.nih.gov/pubmed/37240052
http://dx.doi.org/10.3390/ijms24108707

Ejemplares similares